Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ether doai
Reexamination Certificate
2011-05-17
2011-05-17
Krass, Frederick (Department: 1612)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ether doai
Reexamination Certificate
active
07943670
ABSTRACT:
Described is a soluble stable liquid formulation, process for preparing, and a method of using the soluble stable liquid formulation comprising ractopamine or a physiologically acceptable salt thereof, a liquid nonionic cosolvent, and water.
REFERENCES:
patent: 4690951 (1987-09-01), Anderson et al.
patent: 6231887 (2001-05-01), Gao et al.
patent: 2029407 (1979-07-01), None
patent: WO 02/18436 (2002-03-01), None
Watkins et al, The Effect of Various Levels of Ractopamine Hydrochloride on the Performance and Carcass Characteristics of Finishing Swine, J. Anim Sci. 1990 68: 3588-3595.
Strickley, Robert G., “Solubilizing excipients in oral and injectable formulations,”Pharmaceutical Research, 21(2):201-230 (Feb. 2004).
Uttaro, B., et al., “Effect of ractopamine and sex on growth, carcass characteristics, processing yield, and meat quality characteristics of crossbred swine,”Journal of Animal Science, 71(9):2349 (1993).
Burton, Sr. Michael David
Klink Paul Reuben
Demeter John C.
Eli Lilly and Company
Krass Frederick
Packard Benjamin
Sales James J.
LandOfFree
Liquid formulations of ractopamine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Liquid formulations of ractopamine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Liquid formulations of ractopamine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2656579